The height gain (FAH–initial PAH) in the GnRHa + GH group was 9.22 ± 6.03 cm, which was significantly higher than in the GnRHa group (4.72 ± 5.01 cm, P < 0.001) (Table 3). This evidence concerns the gene GH1 and pulmonary arterial hypertension.